RecruitingNCT05999084

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

Studying Early-onset autosomal dominant Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
James J Lah, MD, PhD
Emory University
Intervention
Anti-amyloid Monoclonal Antibodies (mAbs)(drug)
Enrollment
735 target
Eligibility
50-90 years · All sexes
Timeline
20252028

Study locations (8)

Collaborators

Centers for Medicare and Medicaid Services

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05999084 on ClinicalTrials.gov

Other trials for Early-onset autosomal dominant Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for Early-onset autosomal dominant Alzheimer disease

← Back to all trials